Monday, December 06, 2021 8:04:22 PM
New York Yankees and Duke Basketball
Recent ACET News
- Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/28/2024 09:00:00 PM
- Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma • Business Wire • 06/24/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:11:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:06:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:04:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:03:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 11:01:53 AM
- Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis • Business Wire • 06/05/2024 11:00:00 AM
- Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/31/2024 09:41:00 PM
- Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference • Business Wire • 05/29/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:03:01 PM
- Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates • Business Wire • 05/14/2024 08:01:00 PM
- Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress • Business Wire • 05/14/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 10:09:04 AM
- Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference • Business Wire • 05/07/2024 11:00:00 AM
- Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/30/2024 09:10:00 PM
- Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting • Business Wire • 04/22/2024 08:30:00 PM
- Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference • Business Wire • 04/08/2024 11:00:00 AM
- Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/28/2024 09:19:00 PM
- Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress • Business Wire • 03/19/2024 08:10:00 PM
- Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference • Business Wire • 03/11/2024 11:00:00 AM
- Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/01/2024 12:46:00 AM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM